Royce Morrison, MD, CPI

Royce Morrison, MD, CPI is Chief Medical Officer for Comprehensive Clinical Development. Sited at the company’s Tacoma, WA clinical pharmacology research facility, he has served as principal investigator for early-phase studies, Director of Medical Affairs, and Director of Clinical Strategy since 2002. He led development of capabilities in cardiac safety and radiolabeled studies. With colleagues at Comprehensive’s three early-phase sites, he provides strategic and protocol design consultation.

Dr. Morrison earned BS and MS degrees in electrical engineering, then MD, at Stanford University. He practiced consultative and primary care internal medicine in private practice and HMO settings, emphasizing geriatrics and HIV/AIDS care. For Group Health Cooperative, he participated in evidence review, guidelines development, formulary decisions and contractual coverage determinations. After cofounding a venture-financed consumer health information company, he joined Northwest Kinetics, which became a leader among single-site clinical pharmacology units and was acquired (2006) by Charles River, then (2011) by Comprehensive Clinical Development.

A Past President of NWABR, Dr. Morrison also participates on the Board of the Association of Clinical Pharmacology Units and in ACCP, DIA and its Clinical Pharmacology SIAC Core Committee, ASCPT, American College of Physicians/American Society of Internal Medicine, Academy of Pharmaceutical Physicians and Investigators (Certified Physician Investigator), and American Society of Clinical Oncology.